Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
Conditions:   Voiding Disorders;   Overactive Bladder Interventions:   Drug: Beta3-Agonists, Adrenergic;   Drug: Anticholinergic drug, Solifenacin Sponsor:   Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2022 Category: Research Source Type: clinical trials